India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials

Credit: Fossbytes- Published 2 days ago
Hyderabad-based Bharat Biotech has developed a potential vaccine to combat the Covid-19 disease. The vaccine is named Covaxin and represents India’s effort in curbing down the spread of Coronavirus that has ravaged countries across the globe. Covaxin contains a weakened version of the SARS-CoV-2 virus (Coronavirus) which will...

Video credit: Wochit
Published 14 hours ago -  00:37
Coronavirus Vaccine: How Close Are We?
Researchers around the world are developing more than 145 vaccines against the coronavirus. 19 vaccines are in human trials but vaccines typically require years of research and testing. Scientists are racing to produce a safe and effective vaccine by next year, says Business Insider. The first vaccine safety trials in humans started in March, but the road ahead remains uncertain. Some trials will fail, and others may end without a clear result. But a few may succeed in stimulating the immune system to produce effective antibodies.

You are here

Related videos from verified sources

China Approves COVID-19 Vaccine For Military Use 00:30
Credit: Wochit - Published 1 day ago 


Covid update: Bihar wedding hotspot; new virus in China; EU bars Indians 04:15
Credit: HT Digital Content - Published 1 day ago 


Race to create a vaccine 02:29
Credit: KTNV Channel 13 Las Vegas - Published 2 days ago 


Related news from verified sources

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
3 days ago • IndiaTimes

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human...
2 days ago • Mid-Day